Zobrazeno 1 - 10 of 77 pro vyhledávání: '"Lynn A. Rose"'
1
Akademický článek
PMDedu: Assessing the educational needs of startups and academic investigators focused on pediatric medical device development
Autor: Payal Shah, Alexis Snitman, Jennifer McCaney, Lynn M. Rose, David Sheridan, Juan Espinoza Salomon
Publikováno v: Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Background: The pediatric medical device development (PMDD) process is highly complex, beset by a variety of financial, technical, medical, and regulatory barriers. Startup company innovators and academic investigators often struggle with a
Externí odkaz: https://doaj.org/article/5e3b808df0ad41c2ae61581dd166311d
Zobrazit plný text záznamu
2
Akademický článek
Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors
Autor: Lynn M. Rose, Hannah A. DeBerg, Prakash Vishnu, Jason K. Frankel, Adarsh B. Manjunath, John Paul E. Flores, David M. Aboulafia
Publikováno v: Frontiers in Oncology, Vol 10 (2021)
Checkpoint inhibitors (CPIs) increase antitumor activity by unblocking regulators of the immune response. This action can provoke a wide range of immunologic and inflammatory side effects, some of which can be fatal. Recent studies suggest that CPI-i
Externí odkaz: https://doaj.org/article/88f695767baf441e8314cd3c5cd60d1f
Zobrazit plný text záznamu
3
Akademický článek
Collaborative academic medical product development: An 8-year review of commercialization outcomes at the Institute of Translational Health Sciences
Autor: Lynn M. Rose, Fiona Wills, Connie Bourassa-Shaw, Terri L. Butler, Jeanette Griscavage Ennis, Kim Emmons, Patrick Shelby, Meher Antia, Kim Folger Bruce
Publikováno v: Journal of Clinical and Translational Science, Vol 1, Pp 229-234 (2017)
Introduction The Institute of Translational Health Sciences (ITHS), a Clinical and Translational Science Award (CTSA)-funded program at the University of Washington (UW), established the Drug and Device Advisory Committee (DDAC) to provide product-s
Externí odkaz: https://doaj.org/article/94e9a80a5baf40bc8e12f33a3fded50d
Zobrazit plný text záznamu
5
Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study
Autor: Bryan Kestenbaum, Andrew N. Hoofnagle, Leila R. Zelnick, Cora M Best, Kenneth E. Thummel, Lynn M. Rose, Simon Hsu, Yvonne S. Lin, Ian H. de Boer
Publikováno v: J Am Soc Nephrol
BACKGROUND: Conversion of 25-hydroxyvitamin D (25[OH]D) to the active form of vitamin D occurs primarily in the kidney. Observational studies suggest 25(OH)D clearance from the circulation differs by kidney function and race. However, these potential
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565c0e4d833379d51c5b7fa02b4af613
https://doi.org/10.1681/asn.2020050625
Zobrazit plný text záznamu
6
Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors
Autor: Hannah A. DeBerg, John Paul Flores, David M. Aboulafia, Adarsh B. Manjunath, Jason Frankel, Prakash Vishnu, Lynn M. Rose
Publikováno v: Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Checkpoint inhibitors (CPIs) increase antitumor activity by unblocking regulators of the immune response. This action can provoke a wide range of immunologic and inflammatory side effects, some of which can be fatal. Recent studies suggest that CPI-i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3a8869d85051a36934292c811b9629
http://europepmc.org/articles/PMC7844139
Zobrazit plný text záznamu
7
Collaborative academic medical product development: An 8-year review of commercialization outcomes at the Institute of Translational Health Sciences
Autor: Terri L. Butler, Lynn M. Rose, Fiona Wills, Patrick Shelby, Kim Emmons, Kim Folger Bruce, Meher Antia, Connie Bourassa-Shaw, Jeanette Griscavage Ennis
Publikováno v: Journal of Clinical and Translational Science
IntroductionThe Institute of Translational Health Sciences (ITHS), a Clinical and Translational Science Award (CTSA)-funded program at the University of Washington (UW), established the Drug and Device Advisory Committee (DDAC) to provide product-spe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6fc1e38e3f1e11c7b7833952a53ed4
https://doi.org/10.1017/cts.2017.13
Zobrazit plný text záznamu
9
Academic Medical Product Development: An Emerging Alliance of Technology Transfer Organizations and the CTSA
Autor: Nathaniel Hafer, Lynn M. Rose, Christine Burke, Scott J. Steele, Maaike Everts, Caren Heller
Publikováno v: Clinical and Translational Science. 7:456-464
To bring the benefits of science more quickly to patient care, the NIH National Center Advancing Translational Sciences (NCATS) supports programs that enhance the development, testing, and implementation of new medical products and procedures. The NC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30ae187192a6209e3c11b46762bfcd2e
https://doi.org/10.1111/cts.12175
Zobrazit plný text záznamu
10
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Autor: Bonnie W. Ramsey, Leslie Hendeles, Michael W. Konstan, Lynn M. Rose, Susan Murray, Richard A. Kronmal, Susan Casey, Wayne J. Morgan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla
Publikováno v: Clinical Investigation. 3:731-741
In 2006, the US FDA issued a ‘Guidance for Industry’ regarding submission of New Drug Applications for pancreatic enzyme replacement therapy (PERT) products. Five oral delayed-release PERT products have been approved by the FDA, and several other
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b44fc2e65ca4106144f8b21944a6da7
https://doi.org/10.4155/cli.13.63
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje